Getting your drug to market faster. Better. For patients around the world.
Agile. Innovative. Global.
Our ServicesCelerion’s commitment to swift, exceptional research through translational medicine.
Every day, we use our experience, agility, and innovative research strategies to help get your drug to market faster—so your treatments can touch the lives of family, friends, and people in need around the world.
Early Phase Clinical Services
Delivering Early Phase Confidence Through Expertise and Experience
With 50+ years of experience and more than 650 beds worldwide, we offer the largest global network of early phase operations in the industry. Find out how our expertise, facilities, and full range of clinical research services prepare us to address the unique needs of your product’s early phase development.
Bioanalytical Sciences
For over 50 years, we’ve delivered swift, robust bioanalytical data from the analysis of small and large molecules in every phase of drug development. From design to execution and analysis, learn how we’ll address your study’s bioanalytical needs.
Therapeutic Expertise Areas
Focused on Strong Science and Flawless Execution
Between our comprehensive services and decades of therapeutic experience, we have the expertise to handle every aspect of your product’s early development—no matter the type of drug or clinical trial. These are some of the many specialties we’ve cultivated over the years, to provide fast, innovative solutions for your drug’s development.
What Sets Us Apart
AGILE
Speed is part of our name. We optimize our studies for speed and efficiency at every stage, to generate actionable data faster than our competitors.
EXPERIENCED
Our 50+ years of experience conducting 6,000+ studies ensures the collection of quality data through efficient and effective study designs.
GLOBAL
With facilities across North America, Europe, and Asia, in 30 countries worldwide, we conduct trials with the right patients, in the right places, to get the data you need.
INNOVATIVE
From data acquisition strategies to advanced facilities, we lead the way in leveraging new technology to provide faster, more accurate data, at less cost.
Celerion Events
Latest News and Resources
Blog
The Resurgence of Antibody Drug Conjugates: How ADCs are tak...
Michelle Miller, PhD, Global Senior Scientific Director, Bioanalytical Services What is an ADC? Anti...
News
Celerion Welcomes Dr. Steven Evans as Senior Cardiologist to...
LINCOLN, Neb.; Nov. 20, 2025 (Business Wire) – Celerion, a global leader in early-stage clinical res...
News
Celerion Earns AAHRPP Full Reaccreditation for Five Years, S...
LINCOLN, Neb.; Oct 9, 2025 (Business Wire) – Celerion, a leader in early clinical research...